Opens in a new tab
Friday, 20 November 2026
EVIDENCE. INTERPRETED.
Pharmacally

Atopic Dermatitis

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Latest in Atopic Dermatitis

18 stories · every one Fact-Checked
Gemini_Generated_Image_zbcc04zbcc04zbccHealth TidingsArcutis’ ZORYVE Cream sNDA Accepted by FDA for Infants with Atopic DermatitisFDA has accepted Arcutis’ supplemental NDA for ZORYVE cream 0.05% in infants aged 3 to 24 months with atopic dermatitis.8 Jul 2026 · 3 min read
Fact-Checked
Gemini_Generated_Image_yjzre8yjzre8yjzrClinical TrialsTurn Therapeutics Reports Interim Phase 2 Results, Finalizes Stage 2 Trial Design for GX-03 in Atopic DermatitisTurn Therapeutics has reported encouraging interim Phase 2 findings for GX-03 in atopic dermatitis while finalizing the Stage 2 design of its adaptive trial.8 Jul 2026 · 3 min read
Fact-Checked
Incyte_logo.svgHealth TidingsCHMP Backs Opzelura Cream for Moderate Atopic Dermatitis in Adults Across EuropeThe European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Opzelura® (ruxolitinib) cream for adults with moderate atopic dermatitis (AD) who cannot…26 Jun 2026 · 3 min read
Fact-Checked
Gemini_Generated_Image_ye1doqye1doqye1dClinical TrialsShionogi Advances Tapinarof With Positive Infant Atopic Dermatitis DataShionogi & Co., Ltd. and Torii Pharmaceutical Co., Ltd. announced encouraging interim Phase 3 data for tapinarof cream 0.5% in infants aged 3 months to under 24 months…20 May 2026 · 2 min read
Fact-Checked
Gemini_Generated_Image_3o1ubs3o1ubs3o1uClinical TrialsSanofi Reports Phase 3 Success for Amlitelimab in Atopic DermatitisAmlitelimab met primary endpoints across three Phase 3 trials in moderate-to-severe atopic dermatitis, showing consistent improvements in skin clearance, disease severity, and itch with a favorable safety profile.28 Mar 2026 · 3 min read
Fact-Checked
2149329641Health TidingsOrganon Highlights Week 1 Improvements with VTAMA in Atopic DermatitisNew pooled analysis from ADORING 1 and 2 trials shows VTAMA cream provides rapid and sustained improvements in itch and skin severity in atopic dermatitis, with significant responses…28 Mar 2026 · 3 min read
Fact-Checked
Page 2 of 2